Trial · NCT00520936
Adverse events43
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 43
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Infection with normal ANC or Grade 1 | Blood and lymphatic system disorders | Pemetrexed | 2 | 72 | 2 |
| other | Dermatology/Skin - Other | Cardiac disorders | Pemetrexed | 1 | 72 | 1 |
| other | Pulmonary/Upper Respiratory - Other | Cardiac disorders | Pemetrexed | 1 | 72 | 1 |
| other | Thrombosis/thrombus/embolism | Cardiac disorders | Pemetrexed | 1 | 72 | 1 |
| other | Sodium, serum-low | Congenital, familial and genetic disorders | Pemetrexed | 1 | 72 | 1 |
| other | Diarrhea | Gastrointestinal disorders | Pemetrexed | 1 | 72 | 1 |
| other | Hemorrhage, GI: Rectum | Gastrointestinal disorders | Pemetrexed | 1 | 72 | 1 |
| other | Pain: Tumor pain | Gastrointestinal disorders | Pemetrexed | 1 | 72 | 1 |
| other | Fever | General disorders | Pemetrexed | 2 | 72 | 2 |
| other | Seizure | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Pemetrexed | 2 | 72 | 2 |
| other | Hemorrhage, GU: Urinary NOS | Renal and urinary disorders | Pemetrexed | 1 | 72 | 1 |
| other | Renal failure | Renal and urinary disorders | Pemetrexed | 1 | 72 | 1 |
| other | Hypoxia | Respiratory, thoracic and mediastinal disorders | Pemetrexed | 2 | 72 | 2 |
| serious | Febrile neutropenia | Blood and lymphatic system disorders | Pemetrexed | 4 | 72 | 4 |
| serious | Hemoglobin | Blood and lymphatic system disorders | Pemetrexed | 1 | 72 | 1 |
| serious | Infection | Blood and lymphatic system disorders | Pemetrexed | 2 | 72 | 2 |
| serious | Infection with normal ANC or Grade 1 | Blood and lymphatic system disorders | Pemetrexed | 4 | 72 | 4 |
| serious | Leukocytes | Blood and lymphatic system disorders | Pemetrexed | 3 | 72 | 3 |
| serious | Lymphopenia | Blood and lymphatic system disorders | Pemetrexed | 3 | 72 | 3 |
| serious | Neutrophils/granulocytes | Blood and lymphatic system disorders | Pemetrexed | 3 | 72 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00520936/events